Global Pharmaceuticals & Biotech High ROE Growth Engines

Incyte

Market Cap: US$25.9b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Exelixis

Market Cap: US$13.4b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Orion Oyj

Market Cap: €11.1b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

CSPC Innovation Pharmaceutical

Market Cap: CN¥63.0b

Engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally.

Shanghai Allist Pharmaceuticals

Market Cap: CN¥50.5b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.

Abbott India

Market Cap: ₹561.3b

Operates as a pharmaceutical company in India.

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥38.9b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

3SBio

Market Cap: HK$44.6b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹496.4b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

ACADIA Pharmaceuticals

Market Cap: US$5.1b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

SK Biopharmaceuticals

Market Cap: ₩6.8t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

Ajanta Pharma

Market Cap: ₹447.3b

A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.

Suzhou Zelgen Biopharmaceuticals

Market Cap: CN¥31.2b

Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.

Sumitomo Pharma

Market Cap: JP¥636.1b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

Xiamen Amoytop Biotech

Market Cap: CN¥24.3b

Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.1b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Neuland Laboratories

Market Cap: ₹294.1b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س9.8b

Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.

CareDx

Market Cap: US$2.5b

Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

ADMA Biologics

Market Cap: US$2.2b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Shenyang Xingqi PharmaceuticalLtd

Market Cap: CN¥13.8b

Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.

HBM Holdings

Market Cap: HK$13.9b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

Innoviva

Market Cap: US$1.5b

Operates as a biopharmaceutical company in the United States and internationally.

MeiraGTx Holdings

Market Cap: US$1.4b

A clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases.

CORONA Remedies

Market Cap: ₹131.4b

A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.

ChemoMetec

Market Cap: DKK 8.5b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

BioGaia

Market Cap: SEK 11.8b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Oscotec

Market Cap: ₩1.5t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

Basilea Pharmaceutica

Market Cap: CHF 802.5m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

Soho Global Health

Market Cap: Rp15.2t

Together with its subsidiaires, operates as a healthcare company in Indonesia.

Zevra Therapeutics

Market Cap: US$704.9m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

CorMedix

Market Cap: US$639.1m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Rafa Laboratories

Market Cap: ₪1.5b

A pharmaceutical company, manufactures, markets, and distributes prescription (Rx) and over-the-counter (OTC) medicines in Israel.

DHG Pharmaceutical

Market Cap: ₫12.6t

Engages in the manufacture and sale of pharmaceutical products in Vietnam.

Onconic Therapeutics

Market Cap: ₩659.3b

Engages in the research and development of anti-cancer therapy in South Korea.

Q32 Bio

Market Cap: US$475.4m

A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.